Protagonist Therapeutics Stock Performance
as on November 3, 2026 at 5:08 am IST
Day's Low
Day's High
$141.02$145.91
0.61%
Downside
2.83%
Upside
52 Week's Low
52 Week's High
$75.44$160.8146.83%
Downside
13.33%
Upside
Protagonist Therapeutics share price movements today
- Previous Close
- $144.85
- Open
- $145.00
- Volume
- 128.0K
- Market Cap
- $9.4B
- Day's Low - High
- $141.02 - $145.91
- 52 Week Low - High
- $75.44 - $160.81
Protagonist Therapeutics Historical Returns
- 1 Month Return
- + 3.42 %
- 3 Month Return
- + 6.01 %
- 1 Year Return
- + 84.24 %
- 3 Year Return
- + 839.97 %
- 5 Year Return
- + 349.15 %
Protagonist Therapeutics Stock Fundamentals & Key Indicators
Check Protagonist Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.4B
EPS (TTM)
1.2181
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
3.51%
PE Ratio (TTM)
118.91
Industry PE ratio
-7.37
PEG Ratio
-0.14
EBITDA
85.9M
Revenue (TTM)
282.0M
Profit Margin
99.86%
Return On Equity TTM
12.03%
Protagonist Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Protagonist Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $9.4B | 349.15% | 118.91 | 99.86% | 0.00% | |
| Neutral | $88.5B | -36.40% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 208.09% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 45.26% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Protagonist Therapeutics Stock including INR - Dollar returns
The Protagonist Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Protagonist Therapeutics investment value today
Current value as on today
₹1,93,040
Returns
₹93,040
(+93.04%)
Returns from Protagonist Therapeutics Stock
₹80,476 (+80.48%)
Dollar Impact
₹12,564 (+12.56%)
Analyst Recommendation on Protagonist Therapeutics Stock
Based on 9 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Protagonist Therapeutics. Average target price of $178.57
Protagonist Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Protagonist Therapeutics.
What analysts predicted
20.54%UPSIDE
Target Price
$178.57
Current Price
$141.89
Analyzed by
9 Analysts
High
$182
Target
$178.57
Low
$149
Protagonist Therapeutics target price $178.57, a slight upside of 20.54% compared to current price of $141.89. According to 9 analysts rating.
Indian Investors' Interest in Protagonist Therapeutics Stock
Search interest for Protagonist Therapeutics Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:10% versus previous 30 day period
Protagonist Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Protagonist Therapeutics Annual Profit & Loss
All numbers in Millions USD
Protagonist Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Protagonist Therapeutics Annual Cash Flow
All numbers in Millions USD
Protagonist Therapeutics News & Key Events
Today's Timeline - 31 August
Mon, 11:32 PM
-Protagonist Therapeutics receives FDA approval for rusfertide, marking its second approved medicine this year, with significant financial implications.
Insights on Protagonist Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, PTGX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 6 months, PTGX stock has moved up by 47.3%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 632.1%
About Protagonist Therapeutics
| Organisation | Protagonist Therapeutics |
| Headquarters | 7707 Gateway Boulevard, Newark, CA, 94560, US |
| Industry | Biotechnology |
| CEO | Dinesh V. Patel |
Key Management of Protagonist Therapeutics
Name | Title |
|---|---|
Mr. Venkat Thalladi Ph.D. | EVP & Chief Technical Officer |
Dr. Newman Yeilding M.D. | Executive VP, Chief Scientific Officer |
Ms. Abha Bommireddi | Executive VP & Chief of Staff |
Dr. Dinesh V. Patel Ph.D. | CEO, President, Secretary & Director |
Mr. Asif Ali | Executive VP & CFO |
Dr. Arturo M. Molina FACP, M.D., M.S. | Chief Medical Officer |
Mr. Matthew M. Gosling J.D. | Executive VP and Chief Legal & Business Officer |
Ms. Carena Spivey | Executive VP & Chief Human Resources Officer |
Dr. Ashok Bhandari Ph.D. | EVP & Chief Discovery Officer |
Mr. Carter J. King | Executive Vice President of Business Development |
FAQs
What is Protagonist Therapeutics share price today?
Protagonist Therapeutics share price today is $141.89 as on . Protagonist Therapeutics share today touched a day high of $145.91 and a low of $141.02.
What is the 52 week high and 52 week low for Protagonist Therapeutics share?
Protagonist Therapeutics share touched a 52 week high of $160.81 on and a 52 week low of $75.44 on . Protagonist Therapeutics stock price today i.e. is trending at $141.89,which is 11.77% down from its 52 week high and 88.08% up from its 52 week low.
What is Protagonist Therapeutics's market capitalisation today?
Protagonist Therapeutics market capitalisation is $0.01T as on .
How to invest in Protagonist Therapeutics Stock (PTGX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Protagonist Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Protagonist Therapeutics Stock (PTGX) from India?
Indian investors can start investing in Protagonist Therapeutics (PTGX) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Protagonist Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Protagonist Therapeutics share’s latest price of $141.89 as on November 2, 2026 at 11:38 pm IST, you will get 0.0705 shares of Protagonist Therapeutics. Learn more about
fractional shares .
What are the returns that Protagonist Therapeutics has given to Indian investors in the last 5 years?
Protagonist Therapeutics stock has given 349.15% share price returns and 27.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?